Tami Daugherty is a Gastroenterology physician affiliated with Emergency University. OpenAlex indexes 67 publications with 682 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Palo Alto, CA 943042203
Telephone
650-723-4000Provider last certified this registry record 28 Apr 2024.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mauna Kea Technologies, Inc.Program year20251 payment
- Ethicon US, LLCProgram year20241 payment
- ABBVIE INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
36%Calcineurin inhibitor34.3%Tacrolimus77%Cyclosporine Modified12%Cyclosporine6%Prograf5%Part D<11 patientsKinase inhibitor1.7%Sirolimus100%Part D<11 patientsMetabolism & gastrointestinal
30%Proton pump inhibitor9.4%Pantoprazole Sodium82%Omeprazole18%Part D<11 patientsBile Acid8.5%Ursodiol100%Part D≥21 patients+ 4 more classes in this area
Anti-infectives
17%Nucleoside and nucleotide reverse transcriptase inhibitors8.5%Vemlidy52%Tenofovir Disoproxil Fumarate48%Part D<11 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor7.1%Entecavir100%Part D≥11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Changes in the liver transplant evaluation process during the early COVID-19 era and the role of telehealth
World Journal of Transplantation
2025 - Survival Benefit of Liver Transplantation in the Modern Era Across All MELD Categories
American Journal of Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”